{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:19:35Z","timestamp":1782901175825,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2562,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/ki.2008.543","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T08:38:12Z","timestamp":1227688692000},"page":"S88-S93","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S111","title":["Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients"],"prefix":"10.1016","volume":"74","author":[{"given":"Ana M.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Albalate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Caramelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.543_bb0010","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodistrophy: a position statement from kidney disease. Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1038\/ki.2008.543_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","article-title":"Vascular calcification and renal osteodystrophy relationship in chronic kidney disease","volume":"36","author":"Moe","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/ki.2008.543_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI Clinical Practice Guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.543_bb0025","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135-achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.543_bb0030","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.543_bb0035","first-page":"S1:1","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Nefrolog\u00eda para el Manejo de las Alteraciones del metabolismo \u00f3seo-mineral en los pacientes con enfermedad renal cr\u00f3nica","volume":"28","author":"Torregrosa","year":"2008","journal-title":"Nefrolog\u00eda"},{"key":"10.1038\/ki.2008.543_bb0040","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.543_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1038\/ki.2008.543_bb0050","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.ajkd.2007.12.018","article-title":"Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999\u20132004","volume":"51","author":"Vassalotti","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.543_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.543_bb0060","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.543_bb0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.543_bb0070","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.543_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.543_bb0080","first-page":"1","article-title":"Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden","volume":"24","author":"Hutchison","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.543_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1525-139X.2008.00440.x","article-title":"Nonphosphate-binding effects of sevelamer-are they of clinical relevance?","volume":"21","author":"Marangon","year":"2008","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.543_bb0090","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/ndt\/gfn151","article-title":"Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function","volume":"23","author":"Heinrich","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.543_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.543_bb0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.543_bb0105","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2215\/CJN.05161107","article-title":"Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis","volume":"3","author":"Ketteler","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.543_bb0110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2006.08.019","article-title":"J-shaped mortality relationship for uric acid in CKD","volume":"48","author":"Suliman","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.543_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2008.543_bb0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Card\u00fas","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1038\/ki.2008.543_bb0125","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.543_bb0130","first-page":"123","article-title":"Different biological functions in PHT molecules. What are we measuring?","volume":"28","author":"De la Piedra","year":"2008","journal-title":"Nefrologia"},{"issue":"Suppl 3","key":"10.1038\/ki.2008.543_bb0135","first-page":"S1","article-title":"K\/DOQI Workgroup. Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients","volume":"4","year":"2005","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T23:29:53Z","timestamp":1545607793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815532420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"alternative-id":["S0085253815532420"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.543","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}